Cover Image

A Markov model of fibrosis development in nonalcoholic fatty liver disease predicts fibrosis progression in clinical cohorts

Abstract Disease progression in nonalcoholic steatohepatitis (NASH) is highly heterogenous and remains poorly understood. Fibrosis stage is currently the best predictor for development of end‐stage liver disease and mortality. Better understanding and quantifying the impact of factors affecting NASH...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jane Knöchel (Author), Linnéa Bergenholm (Author), Eman Ibrahim (Author), Stergios Kechagias (Author), Sara Hansson (Author), Mathias Liljeblad (Author), Patrik Nasr (Author), Björn Carlsson (Author), Mattias Ekstedt (Author), Sebastian Ueckert (Author)
Format:	Book
Published:	Wiley, 2023-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Liver biopsy in the quantitative assessment of liver fibrosis in nonalcoholic fatty liver disease
by: Gwyneth Shook Ting Soon, et al.
Published: (2021)

The validity of serum autotaxin as a predictor of hepatic fibrosis in patients with nonalcoholic fatty liver disease
by: Muhammad Abdel-Gawad, et al.
Published: (2023)

The value of noninvasive scoring systems for the diagnosis of advanced fibrosis in Egyptian patients with nonalcoholic fatty liver disease
by: Rokaya A Mohamed, et al.
Published: (2014)

Oxidized High-Density Lipoprotein Shows a Stepwise Increase as Fibrosis Progresses in Patients with Nonalcoholic Fatty Liver Disease
by: Kouichi Miura, et al.
Published: (2021)

Accumulation of free cholesterol and oxidized low-density lipoprotein is associated with portal inflammation and fibrosis in nonalcoholic fatty liver disease
by: Cheng-Maw Ho, et al.
Published: (2019)

Regional fat distribution and hepatic fibrosis and steatosis severity in patients with nonalcoholic fatty liver disease and type 2 diabetes
by: Asieh Mansour, et al.
Published: (2024)

Sex hormone binding globulin (SHBG) as a predictor of liver fibrosis in subjects with nonalcoholic fatty liver disease (NAFLD)
by: Abeer Abdel-latif, et al.
Published: (2023)

Second-Harmonic Generated Quantifiable Fibrosis Parameters Provide Signatures for Disease Progression and Regression in Nonalcoholic Fatty Liver Disease
by: Nicole Ng, et al.
Published: (2023)

S-nitroso-N-acetylcysteine attenuates liver fibrosis in experimental nonalcoholic steatohepatitis
by: Mazo DF, et al.
Published: (2013)

Automated quantification of steatosis: agreement with stereological point counting
by: André Homeyer, et al.
Published: (2017)

S-nitroso-N-acetylcysteine attenuates liver fibrosis in experimental nonalcoholic steatohepatitis [Corrigendum]
by: Mazo DF, et al.
Published: (2013)

Semaglutide in the treatment of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
by: Magdalena Mazurek, et al.
Published: (2023)

Association of Dietary Acid Load with Nonalcoholic Fatty Liver Disease and Advanced Liver Fibrosis in US Adults: Evidence from NHANES 1999–2018
by: Cheng J, et al.
Published: (2023)

Pnpla3 silencing with antisense oligonucleotides ameliorates nonalcoholic steatohepatitis and fibrosis in Pnpla3 I148M knock-in mice
by: Daniel Lindén, et al.
Published: (2019)

Nonalcoholic Fatty Liver Disease An Update
Published: (2019)

Human Liver-Derived Stem Cells Improve Fibrosis and Inflammation Associated with Nonalcoholic Steatohepatitis
by: Stefania Bruno, et al.
Published: (2019)

Patophysiology of nonalcoholic fatty liver disease
by: Ewa Krzewicka-Romaniuk, et al.
Published: (2019)

Patophysiology of nonalcoholic fatty liver disease
by: Ewa Krzewicka-Romaniuk, et al.
Published: (2019)

Nonalcoholic Fatty Liver Disease and Ayurveda
by: Sanjeev Sharma, et al.
Published: (2023)

Analysis of the dietary factors associated with suspected pediatric nonalcoholic fatty liver disease and potential liver fibrosis: Korean National Health and Nutrition Examination Survey 2014-2017
by: Mi Jin Kim, et al.
Published: (2020)

Exposure-response modeling for nausea incidence for cotadutide using a Markov modeling approach
by: Hongtao Yu, et al.
Published: (2024)

Spotlight on inhaled ciprofloxacin and its potential in the treatment of non-cystic fibrosis bronchiectasis
by: Chorepsima S, et al.
Published: (2018)

Nonalcoholic fatty liver disease in children and adolescents
by: Hae Sang Lee
Published: (2024)

Nonalcoholic fatty liver disease: New epidemic
by: Rajkumar P Wadhwa, et al.
Published: (2021)

Nonalcoholic fatty liver disease and portal hypertension
by: Marvin Ryou, et al.
Published: (2020)

A combined nanotherapeutic approach targeting farnesoid X receptor, ferroptosis, and fibrosis for nonalcoholic steatohepatitis treatment
by: Jiangtao Fu, et al.
Published: (2024)

Fatty liver in a child: Looking beyond nonalcoholic fatty liver disease
by: Jaya Agarwal, et al.
Published: (2021)

The efficacy of aspartate aminotransferase-to-platelet ratio index for assessing hepatic fibrosis in childhood nonalcoholic steatohepatitis for medical practice
by: Earl Kim, et al.
Published: (2013)

Nonalcoholic fatty liver disease and insulin resistance in children
by: Kyungchul Song, et al.
Published: (2023)

Electrocardiographic and echocardiographic changes in nonalcoholic fatty liver disease
by: Ahmed S Elsawaby, et al.
Published: (2019)

Noninvasive diagnosis of pediatric nonalcoholic fatty liver disease
by: Hye Ran Yang
Published: (2013)

Progressive Scoliosis in a Child with Cystic Fibrosis
by: Lauren M. Castner, et al.
Published: (2019)

Herbal drug discovery for the treatment of nonalcoholic fatty liver disease
by: Tingting Yan, et al.
Published: (2020)

Effect of oleoylethanolamide on diet-induced nonalcoholic fatty liver in rats
by: Long Li, et al.
Published: (2015)

The relationship between folic acid and nonalcoholic fatty liver disease
by: Bing'er Xu, et al.
Published: (2024)

Endoplasmic reticulum stress response in nonalcoholic fatty liver disease
by: Arushana Ali, et al.
Published: (2018)

The effect of neuropsychiatric medication on pediatric nonalcoholic fatty liver disease
by: Jamie L. Ryan, et al.
Published: (2022)

The Role of Innate Immune Cells in Nonalcoholic Fatty Liver Disease
by: Marina Nati, et al.
Published: (2021)

Nonalcoholic fatty liver disease in obese and nonobese pediatric patients
by: Eun Jeong Kim, et al.
Published: (2019)

Metagenome of Gut Microbiota of Children With Nonalcoholic Fatty Liver Disease
by: Yuzhen Zhao, et al.
Published: (2019)